Clinical Trials Directory

Trials / Completed

CompletedNCT05559957

Isolated Oligohydramnios Less Favorable Delivery and Neonatal Outcomes

Isolated Oligohydramnios is Associated With Less Favorable Delivery and Composite Neonatal Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
636 (actual)
Sponsor
Zagazig University · Other Government
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Oligohydramnios happens in 1-5% of term pregnancies. The clinical significance of isolated oligohydramnios been a matter of debate. We aimed in this study to investigate the impact of isolated oligohydramnios on the mode of delivery and risk of adverse perinatal outcome.

Detailed description

Retrospective study conducted in Armed Forces Hospitals of Southern Region, comparing cases with oligohydramnios (amniotic fluid level index \<5) to normal amniotic fluid cases (amniotic fluid level index ≥ 8). Primary outcomes are the mode of delivery and adverse perinatal outcomes (including mortality, NICU admission, low Apgar score and sepsis)

Conditions

Interventions

TypeNameDescription
BEHAVIORALobservation of delivery and neonatal outcomesMONITORING THE DELIVERY MODE EITHER CESAREAN OR VAGINAL, BESIDE THE NEONATAL OUTCOME AND MORBIDITIES IN BOTH GROUPS

Timeline

Start date
2020-01-01
Primary completion
2022-03-01
Completion
2022-05-01
First posted
2022-09-29
Last updated
2022-09-30

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT05559957. Inclusion in this directory is not an endorsement.